|
|
Alaunos Therapeutics, Inc.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Re: Volume and probable stock directionIf the TCRT technology can't reliably cure solid-tumor cancer, then probably nothing ever will. If it succeeds then the SP will be much larger than $3. Owning the shares is well worth the gamble. |
||||||||||||
|
|
return to message board, top of board |
| Msg # | Subject | Author | Recs | Date Posted |
| 120701 | Re: Volume and probable stock direction | Mabel | 2 | 11/30/2022 2:14:48 PM |
